EOLS – Evolus, Inc.
Evolus, Inc. Common StockEOLS
$9.14Name : Evolus, Inc. Common Stock
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $589,307,008.00
EPSttm : -0.89
Evolus, Inc. Common Stock
$9.14
1.83%$0.17Float Short %
18.6
Margin Of Safety %
Put/Call OI Ratio
0.04
EPS Next Q Diff
0.19
EPS Last/This Y
0.68
EPS This/Next Y
0.71
Price
9.15
Target Price
23.57
Analyst Recom
1
Performance Q
-25.33
Relative Volume
0.72
Beta
0.99
Ticker: EOLS
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | EOLS | 9.97 | 0.01 | 0.00 | 15730 |
| 2025-06-03 | EOLS | 9.98 | 0.01 | 999.99 | 15889 |
| 2025-06-04 | EOLS | 9.8 | 0.01 | 0.00 | 15894 |
| 2025-06-05 | EOLS | 9.73 | 0.01 | 0.00 | 15938 |
| 2025-06-06 | EOLS | 10.05 | 0.01 | 0.00 | 16006 |
| 2025-06-09 | EOLS | 9.66 | 0.01 | 0.00 | 16008 |
| 2025-06-10 | EOLS | 9.88 | 0.01 | 0.00 | 16008 |
| 2025-06-11 | EOLS | 10.24 | 0.01 | 0.00 | 16002 |
| 2025-06-12 | EOLS | 10.19 | 0.01 | 174.00 | 16637 |
| 2025-06-13 | EOLS | 9.95 | 0.02 | 1.57 | 16809 |
| 2025-06-16 | EOLS | 9.97 | 0.03 | 17.25 | 17045 |
| 2025-06-17 | EOLS | 9.27 | 0.03 | 0.47 | 17080 |
| 2025-06-18 | EOLS | 9.3 | 0.04 | 5.00 | 17610 |
| 2025-06-20 | EOLS | 9.27 | 0.04 | 0.15 | 17596 |
| 2025-06-23 | EOLS | 9.39 | 0.04 | 0.19 | 16430 |
| 2025-06-24 | EOLS | 9.61 | 0.04 | 0.03 | 16584 |
| 2025-06-25 | EOLS | 9.1 | 0.04 | 0.00 | 16854 |
| 2025-06-26 | EOLS | 9.31 | 0.04 | 0.00 | 17062 |
| 2025-06-27 | EOLS | 9.14 | 0.04 | 0.99 | 17063 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | EOLS | 9.94 | -42.6 | 10.3 | -0.13 |
| 2025-06-03 | EOLS | 9.96 | -42.6 | 12.2 | -0.13 |
| 2025-06-04 | EOLS | 9.80 | -42.6 | 12.5 | -0.13 |
| 2025-06-05 | EOLS | 9.74 | -42.6 | 12.3 | -0.13 |
| 2025-06-06 | EOLS | 10.02 | -42.6 | 11.4 | -0.13 |
| 2025-06-09 | EOLS | 9.65 | -42.6 | 13.0 | -0.13 |
| 2025-06-10 | EOLS | 9.88 | -42.6 | 11.6 | -0.13 |
| 2025-06-11 | EOLS | 10.25 | -42.6 | 11.2 | -0.13 |
| 2025-06-12 | EOLS | 10.18 | -42.6 | 12.2 | -0.13 |
| 2025-06-13 | EOLS | 9.94 | -42.6 | 12.6 | -0.13 |
| 2025-06-16 | EOLS | 9.96 | -42.6 | 12.0 | -0.13 |
| 2025-06-17 | EOLS | 9.26 | -42.6 | 13.7 | -0.13 |
| 2025-06-18 | EOLS | 9.30 | -42.6 | 12.0 | -0.13 |
| 2025-06-20 | EOLS | 9.28 | -42.6 | 12.2 | -0.13 |
| 2025-06-23 | EOLS | 9.39 | -42.6 | 11.8 | -0.13 |
| 2025-06-24 | EOLS | 9.62 | -42.6 | 11.5 | -0.13 |
| 2025-06-25 | EOLS | 9.11 | -42.6 | 13.3 | -0.13 |
| 2025-06-26 | EOLS | 9.30 | -42.6 | 11.7 | -0.13 |
| 2025-06-27 | EOLS | 9.15 | -42.6 | 12.5 | -0.13 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | EOLS | -2.63 | 5.51 | 16.23 |
| 2025-06-03 | EOLS | -2.63 | 5.51 | 16.23 |
| 2025-06-04 | EOLS | -2.63 | 5.51 | 16.23 |
| 2025-06-05 | EOLS | -2.63 | 5.51 | 16.23 |
| 2025-06-06 | EOLS | -2.63 | 5.51 | 16.23 |
| 2025-06-09 | EOLS | -2.63 | 5.53 | 16.23 |
| 2025-06-10 | EOLS | -2.63 | 5.53 | 16.23 |
| 2025-06-11 | EOLS | -2.38 | 5.53 | 16.98 |
| 2025-06-12 | EOLS | -2.38 | 5.53 | 16.98 |
| 2025-06-13 | EOLS | -2.38 | 5.53 | 16.98 |
| 2025-06-16 | EOLS | -3.95 | 5.53 | 16.99 |
| 2025-06-18 | EOLS | -3.95 | 5.53 | 16.99 |
| 2025-06-20 | EOLS | -3.95 | 5.53 | 16.99 |
| 2025-06-23 | EOLS | -3.95 | 5.53 | 16.95 |
| 2025-06-24 | EOLS | -4.02 | 5.53 | 16.95 |
| 2025-06-25 | EOLS | -4.02 | 5.53 | 16.95 |
| 2025-06-26 | EOLS | -4.02 | 5.53 | 18.60 |
| 2025-06-27 | EOLS | -3.84 | 5.53 | 18.60 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.25
Avg. EPS Est. Current Quarter
-0.09
Avg. EPS Est. Next Quarter
-0.06
Insider Transactions
-3.84
Institutional Transactions
5.53
Beta
0.99
Average Sales Estimate Current Quarter
82
Average Sales Estimate Next Quarter
85
Fair Value
Quality Score
33
Growth Score
54
Sentiment Score
5
Actual DrawDown %
48.7
Max Drawdown 5-Year %
-68.4
Target Price
23.57
P/E
Forward P/E
16.16
PEG
P/S
2.14
P/B
P/Free Cash Flow
EPS
-0.89
Average EPS Est. Cur. Y
-0.13
EPS Next Y. (Est.)
0.58
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-20.4
Relative Volume
0.72
Return on Equity vs Sector %
827.1
Return on Equity vs Industry %
843.7
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
12.5
Evolus, Inc. Common StockSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 372
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
stock quote shares EOLS – Evolus, Inc. Stock Price stock today
news today EOLS – Evolus, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch EOLS – Evolus, Inc. yahoo finance google finance
stock history EOLS – Evolus, Inc. invest stock market
stock prices EOLS premarket after hours
ticker EOLS fair value insiders trading